An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
Clinical trial NCT00042393 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00042393
- Sponsor
- Gilead Sciences
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.